Nilaya Varma, Co-Founder & Group CEO states that India's pharmaceutical industry has emerged as a global benchmark for affordable, high-quality healthcare solutions. As the sector advances, equal emphasis must now be placed on ensuring medicines remain safe, traceable and effective throughout their lifecycle. Our report estimates that nearly ₹48,000 crore in pharmaceutical value is lost annually due to preventable inefficiencies. Strengthening medicine recall frameworks, digital traceability and structured recovery systems can enhance patient safety, improve supply chain efficiency and further reinforce India's position as a trusted global pharmaceutical leader.